Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SanJoint
- Development stage
- Unknown
- Lead developer
- Sanrey Therapeutics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
SanJoint is an oral joint health and anti-inflammatory nutraceutical supplement developed by Sanrey Therapeutics. It is formulated as a combination of Boswellia serrata extract, chondroitin sulfate sodium, curcumin, glucosamine sulfate potassium chloride, hyaluronic acid, and methylsulfonylmethane (MSM). These ingredients work synergistically to support joint comfort, reduce stiffness, and promote cartilage repair in degenerative joint conditions such as osteoarthritis and rheumatoid arthritis. Specifically, Boswellia serrata and curcumin act as anti-inflammatory agents by inhibiting arachidonate 5-lipoxygenase (ALOX5) and prostaglandin G/H synthase 2 (PTGS2/COX-2), thereby reducing the production of pro-inflammatory leukotrienes and prostaglandins. Glucosamine and chondroitin serve as essential building blocks for glycosaminoglycans and proteoglycans in articular cartilage, while hyaluronic acid binds to CD44 receptors to improve joint lubrication and synovial fluid viscosity. MSM provides organic sulfur, which is crucial for collagen synthesis and connective tissue maintenance.
- Brand names
- SanJoint
- Other names
- Boswellia serrata + chondroitin sulfate sodium + curcumin + glucosamine sulfate potassium chloride + hyaluronic acid + methylsulfonylmethaneSanjointSanjoint Tablet
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)CD44 (CD44 antigen)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on SanJoint.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SanJoint.